drugset / Trial / NCT00817375
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Non-randomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether pharmacogenomic study predict antidepressant responsiveness in advance before the appearance of the drug effects until 4\~6 weeks after drug administration.
Timeline
- Start
- 2003-02
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | — | — |
| Comparator | Milnacipran | Other / unclassified | — | — |
| Comparator | Mirtazapine | Other / unclassified | — | — |
| Comparator | Nortriptyline | Small molecule | — | — |
| Subject | Paroxetine | Small molecule | — | — |
| Subject | Sertraline | Small molecule | — | — |
| Comparator | Venlafaxine | Small molecule | — | — |